MAM
HOOK

Meeder Asset Management’s HOOKIPA Pharma HOOK Stock Holding History

Meeder Asset Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-34
Closed -$3K – 2227
2020
Q1 		$3K Buy
34
+19
+127% +$2.08K ﹤0.01% 1956
2019
Q4 		$2K Buy
+15
New +$1.27K ﹤0.01% 2014

Other funds holding HOOK

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meeder Asset Management's HOOK Position: Q2 2020 in Review

Meeder Asset Management sold out of HOOKIPA Pharma (HOOK) in Q2 2020, closing a stake of 34 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in HOOK in Q4 2019 and held it in 2 quarters. The position peaked at $3K in Q1 2020. 47 funds tracked by Wall St. Rank hold HOOK as of Q2 2020.

  • Meeder Asset Management reported no remaining HOOKIPA Pharma position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 34 HOOKIPA Pharma shares in Q2 2020, an estimated $3K.
  • Meeder Asset Management first reported a position in HOOKIPA Pharma in Q4 2019 and held it in 2 quarters.
  • Meeder Asset Management's HOOKIPA Pharma position peaked at $3K in Q1 2020.
  • 47 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.